The implications of relapses on the evolution of schizophrenia. How to prevent them?

Por Leucht Stefan
Publicado em 2006-02-01

Commentary on strategies for switching antipsychotics

Por Davis, John M, Leucht, Stefan
Publicado em 2008

Unanswered Questions in Schizophrenia Clinical Trials

Por Kane, John M., Leucht, Stefan
Publicado em 2008

Issues in Psychopharmacology

Por Kane, John M., Leucht, Stefan
Publicado em 2008

Has Research Informed Us on the Practical Drug Treatment of Schizophrenia?

Por Davis, John M., Leucht, Stefan
Publicado em 2008

How to Obtain NNT from Cohen's d: Comparison of Two Methods

Por Furukawa, Toshi A., Leucht, Stefan
Publicado em 2011

The PANSS Should Be Rescaled

Por Leucht, Stefan, Kissling, Werner, Davis, John M.
Publicado em 2010

Methodological Issues in Current Antipsychotic Drug Trials

Por Leucht, Stefan, Heres, Stephan, Hamann, Johannes, Kane, John M.
Publicado em 2008

Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials

Por Yildiz, Ayşegül, Vieta, Eduard, Leucht, Stefan, Baldessarini, Ross J
Publicado em 2011

How effective are common medications: a perspective based on meta-analyses of major drugs

Por Leucht, Stefan, Helfer, Bartosz, Gartlehner, Gerald, Davis, John M.
Publicado no BMC Med (2015)

Dose Equivalents for Antipsychotic Drugs: The DDD Method

Por Leucht, Stefan, Samara, Myrto, Heres, Stephan, Davis, John M.
Publicado no Schizophr Bull (2016)

Is the Superior Efficacy of New Generation Antipsychotics an Artifact of LOCF?

Por Leucht, Stefan, Engel, Rolf R., Bäuml, Josef, Davis, John M.
Publicado em 2007

Cortical Dopamine D(2)/D(3) Receptors Are a Common Site of Action for Antipsychotic Drugs—An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Liter...

Por Stone, James M., Davis, John M., Leucht, Stefan, Pilowsky, Lyn S.
Publicado em 2009

Α Markov model for longitudinal studies with incomplete dichotomous outcomes

Por Efthimiou, Orestis, Welton, Nicky, Samara, Myrto, Leucht, Stefan, Salanti, Georgia
Publicado no Pharm Stat (2016)

Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later

Por Lambert, Martin, Karow, Anne, Leucht, Stefan, Schimmelmann, Benno G., Naber, Dieter
Publicado em 2010

Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review

Por Sommer, Iris E., Begemann, Marieke J. H., Temmerman, Anke, Leucht, Stefan
Publicado em 2012

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices

Por Knappich, Moritz, Hörz-Sagstetter, Susanne, Schwerthöffer, Dirk, Leucht, Stefan, Rentrop, Michael
Publicado em 2014

The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects

Por Heilbronner, Urs, Samara, Myrto, Leucht, Stefan, Falkai, Peter, Schulze, Thomas G.
Publicado no Harv Rev Psychiatry (2016)

Should We Treat Depression with drugs or psychological interventions? A Reply to Ioannidis

Por Davis, John M, Giakas, William J, Qu, Jie, Prasad, Pavan, Leucht, Stefan
Publicado em 2011

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

Por Correll, Christoph U., Rummel-Kluge, Christine, Corves, Caroline, Kane, John M., Leucht, Stefan
Publicado em 2009